CD9 and metastatic malignant neoplasm in the lymph nodes: In VSCC, although a direct correlation between CD9 expression and the potential of lymph node metastasis and survival was not statistically significant, we anticipate that patients that are CD9-low or CD9-negative will, more likely, bear tumors that are phenotypically more aggressive and, therefore, have a worse prognosis.